Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies
if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the
same subfield and year (this is the minimum needed to enter the top 1%, not the average
within it), or reaches the top citation threshold in at least one of its specific research
topics.
Countries citing papers authored by R. C. Simsiman
Since
Specialization
Citations
This map shows the geographic impact of R. C. Simsiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. C. Simsiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. C. Simsiman more than expected).
This network shows the impact of papers produced by R. C. Simsiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. C. Simsiman. The network helps show where R. C. Simsiman may publish in the future.
Co-authorship network of co-authors of R. C. Simsiman
This figure shows the co-authorship network connecting the top 25 collaborators of R. C. Simsiman.
A scholar is included among the top collaborators of R. C. Simsiman based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with R. C. Simsiman. R. C. Simsiman is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Reddig, Peter J., H Ahrens, R. C. Simsiman, et al.. (1999). Transgenic mice overexpressing protein kinase Cdelta in the epidermis are resistant to skin tumor promotion by 12-O-tetradecanoylphorbol-13-acetate.. PubMed. 59(22). 5710–8.128 indexed citations
Takigawa, Masaharu, R. C. Simsiman, & R. K. Boutwell. (1986). Tumor promoter-induced refractory state against ornithine decarboxylase induction by 12-O-tetradecanoylphorbol-13-acetate in mouse epidermis.. PubMed. 46(1). 106–12.15 indexed citations
Takigawa, Masaharu, Ajit Kumar Verma, R. C. Simsiman, & R. K. Boutwell. (1983). Inhibition of mouse skin tumor promotion and of promoter-stimulated epidermal polyamine biosynthesis by alpha-difluoromethylornithine.. PubMed. 43(8). 3732–8.88 indexed citations
Mufson, R. Allan, R. C. Simsiman, & R. K. Boutwell. (1979). Increased cyclic adenosine 3':5'-monophosphate phosphodiesterase activity in the epidermis of phorbol ester-treated mouse skin and in papillomas.. PubMed. 39(6 Pt 1). 2036–40.13 indexed citations
Mufson, R. Allan, R. C. Simsiman, & R. K. Boutwell. (1977). The effect of the phorbol ester tumor promoters on the basal and catecholamine-stimulated levels of cyclic adenosine 3':5'-monophosphate in mouse skin and epidermis in vivo.. PubMed. 37(3). 665–9.63 indexed citations
12.
Raineri, R., R. C. Simsiman, & R. K. Boutwell. (1977). Stimulation of the synthesis of mouse epidermal histones by tumor-promoting agents.. PubMed. 37(12). 4584–9.8 indexed citations
Simsiman, R. C., et al.. (1976). The effect of colchicine on the induction of ornithine decarboxylase by 12-O-tetradecanoyl-phorbol-13-acetate.. PubMed. 36(10). 3766–70.26 indexed citations
O’Brien, Thomas G., R. C. Simsiman, & R. K. Boutwell. (1975). Induction of the polyamine-biosynthetic enzymes in mouse epidermis and their specificity for tumor promotion.. PubMed. 35(9). 2426–33.212 indexed citations
17.
Raineri, R., R. C. Simsiman, & R. K. Boutwell. (1973). Stimulation of the phosphorylation of mouse epidermal histones by tumor-promoting agents.. PubMed. 33(1). 134–9.67 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.